PharmaShots | Incisive News in 3 Shots

Subscribe Now

Kern Pharma

Kern Pharma Highlighted P-IV Study Results of CT-P13 (biosimilar, infliximab) for Rheumatic Disease

Kern Pharma Highlighted P-IV Study Results of CT-P13 (biosimilar, infliximab) for Rheumatic Disease

August 24, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us